Bioequivalence of saxagliptin/dapagliflozin fixed‐dose combination tablets compared with coadministration of the individual tablets to healthy subjects

Saxagliptin and dapagliflozin are individually indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The bioequivalence of saxagliptin/dapagliflozin 2.5/5 mg and 5/10 mg fixed‐dose combination (FDC) tablets compared with coadministration of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacol Res Perspect
Main Authors: Vakkalagadda, Blisse, Vetter, Marion L., Rana, Jignasa, Smith, Charles H., Huang, Jian, Karkas, Jennifer, Boulton, David W., LaCreta, Frank
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4777251/
https://ncbi.nlm.nih.gov/pubmed/27022473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.201
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados